Rostami, AliAliRostamiLundström-Stadelmann, BrittaBrittaLundström-Stadelmann0000-0003-2672-5766Frey, Caroline F.Caroline F.Frey0000-0002-6478-7493Beldi, GuidoGuidoBeldi0000-0002-9914-3807Lachenmayer, AnjaAnjaLachenmayerChang, Bill C HBill C HChangNorouzian, Mohammad MobinMohammad MobinNorouzianHemphill, AndrewAndrewHemphillGasser, Robin BRobin BGasser2025-04-222025-04-222025-03-19https://boris-portal.unibe.ch/handle/20.500.12422/208881Alveolar echinococcosis (AE) in humans is caused by the larval (metacestode) stage of Echinococcus multilocularis, commonly known as the 'fox tapeworm'. This disease predominantly targets the liver and has an invasive growth pattern, allowing it to spread to adjacent and distant tissues. Due to its gradual progression and tumour-like characteristics, early diagnosis and prompt intervention are crucial, particularly as there are currently no highly effective vaccines or chemotherapeutics against AE. Current estimates suggest that ~10,500 new infections occur annually worldwide; however, more research is required to refine the prevalence and incidence data for both human and animal hosts in endemic areas of the world. This article discusses the biology of E. multilocularis, outlines aspects of the pathogenesis, diagnosis, treatment, and management of AE, reviews its global distribution, annual incidence, and prevalence, highlights the role of molecular parasitology in advancing therapeutic strategies, and presents recommendations for improving the prevention and control of AE in human populations.enEchinococcus multilocularisalveolar echinococcosisbiologydiagnosishumansincidencepathogenesisprevalencetreatment600 - Technology::630 - Agriculture500 - Science::570 - Life sciences; biologyarticle10.48620/874394014142710.3390/ijms26062784